These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6514131)

  • 1. GABA agonists inhibit the vasopressin-dependent pressor effects of central angiotensin II.
    Brennan TJ; Morris M; Haywood JR
    Neuroendocrinology; 1984 Nov; 39(5):429-36. PubMed ID: 6514131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA agonists inhibit central sodium-induced vasopressin-dependent increases in arterial pressure.
    Brennan TJ; Morris M; Haywood JR
    Eur J Pharmacol; 1984 Aug; 103(3-4):223-34. PubMed ID: 6489442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA inhibition of central angiotensin II and hypertonic CSF pressor responses.
    Brennan TJ; Haywood JR
    Brain Res; 1983 May; 267(2):261-9. PubMed ID: 6871675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabaergic stimulation inhibits central actions of angiotensin II: pressor responses, drinking and release of vasopressin.
    Unger T; Bles F; Ganten D; Lang RE; Rettig R; Schwab NA
    Eur J Pharmacol; 1983 May; 90(1):1-9. PubMed ID: 6873170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central vasopressin raises arterial pressure by sympathetic activation and vasopressin release.
    Janiak P; Kasson BG; Brody MJ
    Hypertension; 1989 Jun; 13(6 Pt 2):935-40. PubMed ID: 2737730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central inhibition by gamma-aminobutyric acid and muscimol of the release of vasopressin and oxytocin by an osmotic stimulus in the rat.
    Bisset GW; Chowdrey HS; Fairhall KM; Gunn LK
    Br J Pharmacol; 1990 Mar; 99(3):529-35. PubMed ID: 2331582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine vasopressin modulates the central action of angiotensin II in the dog.
    Michelini LC; Barnes KL; Ferrario CM
    Hypertension; 1983; 5(6 Pt 3):V94-100. PubMed ID: 6654469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase products in the pithed rat.
    Grant TL; McGrath JC
    Br J Pharmacol; 1988 Dec; 95(4):1220-8. PubMed ID: 3146400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor and angiotensin II: comparison of CNS actions to influence neuroendocrine and cardiovascular function.
    Fisher LA; Brown MR
    Brain Res; 1984 Mar; 296(1):41-7. PubMed ID: 6608972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of GABA in the central regulation of AVP and ANP release and blood pressure due to angiotensin and carbachol, and central GABA release due to blood pressure changes.
    Kimura T; Funyu T; Ohta M; Yamamoto T; Ota K; Shoji M; Inoue M; Sato K; Abe K
    J Auton Nerv Syst; 1994 Dec; 50(1):21-9. PubMed ID: 7844311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anteroventral third ventricle lesions reduce antidiuretic responses to angiotensin II.
    Bealer SL; Phillips MI; Johnson AK; Schmid PG
    Am J Physiol; 1979 Jun; 236(6):E610-5. PubMed ID: 443416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and dipsogenic effects of angiotensin II administered i.c.v. in Long-Evans and Brattleboro rats.
    Harland D; Gardiner SM; Bennett T
    Brain Res; 1988 Jul; 455(1):58-64. PubMed ID: 3416193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intraventricular angiotensin II mediated by the sympathetic nervous system.
    Falcon JC; Phillips MI; Hoffman WE; Brody MJ
    Am J Physiol; 1978 Oct; 235(4):H392-9. PubMed ID: 696880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationship between central bradykinin and vasopressin in conscious rats.
    Brooks DP; Share L; Crofton JT; Nasjletti A
    Brain Res; 1986 Apr; 371(1):42-8. PubMed ID: 3754782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a vasopressin antagonist on the pressor response to histamine administered centrally.
    Gatti PJ; Gertner SB
    Neuropharmacology; 1983 Jul; 22(7):895-902. PubMed ID: 6688661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAergic inhibition of hypertonic saline-induced vasopressin-dependent hypertension.
    Brennan TJ; Haywood JR
    J Pharmacol Exp Ther; 1985 Jun; 233(3):663-71. PubMed ID: 4009486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine enhances the slow-pressor response to angiotensin II in rats. Evidence for a caffeine-angiotensin II interaction with the sympathetic nervous system.
    Ohnishi A; Li P; Branch RA; Holycross B; Jackson EK
    J Clin Invest; 1987 Jul; 80(1):13-6. PubMed ID: 3110209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.